Single-cell and bulk transcriptomic integration identifies a four-gene prognostic score linked to immunometabolic features in osteosarcoma

Background Recurrent and metastatic osteosarcoma calls for prognostic markers that connect tumor-cell states with the metabolic and microenvironmental context of disease progression. We investigated whether recurrence-derived single-cell signals could identify an outcome-associated transcriptional program and functionally informative candidate genes. Methods Single-cell data from GSE152048 were integrated with the 84-patient TARGET-OS cohort to derive a four-gene RiskScore and characterize molecular subtypes, pathway activity, and immune/stromal associations. COL13A1- and KIF25-directed perturbations were examined using transcript and protein measurements, colony formation, and wound-closure assays in 143B and HOS cells. Results Oxidative phosphorylation enrichment characterized both recurrence-derived osteoblast candidates and an outcome-associated molecular subtype. The CGREF1–COL13A1–KIF25–RPL35AP7 score achieved an apparent C-index of 0.814 and 1-, 3-, and 5-year areas under the receiver operating characteristic curve of 0.855, 0.852, and 0.845. RiskScore remained associated with overall survival after adjustment for age, sex, and metastatic status (hazard ratio 2.413, 95% confidence interval 1.769–3.290). Higher scores tracked lower B-lineage, neutrophil, and fibroblast signals. Gene-directed treatments reduced wound closure in both cell lines. COL13A1-directed treatment reduced colony formation in both cell lines, and KIF25-directed treatment reduced colony formation in HOS cells (Dunnett-adjusted P < 0.05). Conclusion This four-gene signature connects osteosarcoma outcome stratification with an immunometabolic and stromal context and identifies COL13A1 and KIF25 as candidates for focused functional investigation.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-13
DOI
https://doi.org/10.3389/fcell.2026.2010244
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Single-cell and bulk transcriptomic integration identifies a four-gene prognostic score linked to immunometabolic features in osteosarcoma

Qiang Li, Sunfu Zhang, Xinhao Peng, Shanshan Zhao et al.
1 links
Frontiers in Cell and Developmental Biology
Sarcoma Diagnosis and Treatment
article

Single-cell and bulk transcriptomic integration identifies a four-gene prognostic score linked to immunometabolic features in osteosarcoma

Qiang Li, Sunfu Zhang, Xinhao Peng, Shanshan Zhao, Jingyue Li, Yijin Wang, Dan Wen, Jun Zhang
article en

Abstract

Background Recurrent and metastatic osteosarcoma calls for prognostic markers that connect tumor-cell states with the metabolic and microenvironmental context of disease progression. We investigated whether recurrence-derived single-cell signals could identify an outcome-associated transcriptional program and functionally informative candidate genes. Methods Single-cell data from GSE152048 were integrated with the 84-patient TARGET-OS cohort to derive a four-gene RiskScore and characterize molecular subtypes, pathway activity, and immune/stromal associations. COL13A1- and KIF25-directed perturbations were examined using transcript and protein measurements, colony formation, and wound-closure assays in 143B and HOS cells. Results Oxidative phosphorylation enrichment characterized both recurrence-derived osteoblast candidates and an outcome-associated molecular subtype. The CGREF1–COL13A1–KIF25–RPL35AP7 score achieved an apparent C-index of 0.814 and 1-, 3-, and 5-year areas under the receiver operating characteristic curve of 0.855, 0.852, and 0.845. RiskScore remained associated with overall survival after adjustment for age, sex, and metastatic status (hazard ratio 2.413, 95% confidence interval 1.769–3.290). Higher scores tracked lower B-lineage, neutrophil, and fibroblast signals. Gene-directed treatments reduced wound closure in both cell lines. COL13A1-directed treatment reduced colony formation in both cell lines, and KIF25-directed treatment reduced colony formation in HOS cells (Dunnett-adjusted P < 0.05). Conclusion This four-gene signature connects osteosarcoma outcome stratification with an immunometabolic and stromal context and identifies COL13A1 and KIF25 as candidates for focused functional investigation.

Frontiers in Cell and Developmental BiologyVol. 14
Third People's Hospital of Chengdu (CN), Southwest Jiaotong University (CN)
Natural Science Foundation of Sichuan Province
Good health and well-being
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon